Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005.
Poulter
Neil
N
Hughes
Alan D
AD
Williams
Bryan
B
Brady
Adrian J B
AJ
McInnes
Gordon
G
D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D006331:Heart Diseases / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012955:Societies, Medical; D020521:Stroke / Q000517:prevention & control; D006113:United Kingdom
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors